Because of renewed interest in a possible connection between carnitine, lipid disorders, and myopathy, an automated method of analysis Is desirable. Deproteinlzatlon of serum by use of membranefilter cones and automated assay with a bichromatic analyzer (the ABA-100) substantially increases efficiency without sacrificing the specificity and accuracy of the original manual enzymatic L-Carnitine (y-trimethylamino-9-hydroxybutyric acid) is essential for the transport of free fatty acids into mitochondria (1). Carnitine deficiency has been associated with several cases of myopathy (2-7) and may play an important role in at least some disorders of lipid metabolism.
L-Carnitine
(y-trimethylamino-9-hydroxybutyric acid) is essential for the transport of free fatty acids into mitochondria (1) . Carnitine deficiency has been associated with several cases of myopathy (2) (3) (4) (5) (6) (7) and may play an important role in at least some disorders of lipid metabolism.
We were interested in devising a method of L-carnitine determination suitable for mass-screening programs. A previously described enzymatic method (8) was not suitable for this purpose because of a tedious deproteinization step as well as the instrumentation involved. Use of membrane filter cone ifitration and an automated bichromatic analyzer appears to provide a carnitine assay method that is suitable for high-volume quantitative analysis of serum or urine. Essentially, the proposed procedure saves time and reagents without sacrificing the specificity and accuracy of the original method. Centre 
Materials and Methods

Principle (8)
Serum is deproteinized by using Amicon membrane cones and L-carnitine determined by the carnitine acetyltransferase (EC 2.3.1.7) reaction: L-carnitine + acetyl CoA acetyl carnitine + CoA. The free CoA then combines with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) and forms thiophenolate ion, the concentration of which is measured as A, 415/550 nm, 550 nm being the wavelength used to correct for nonspecific absorbance at 415
Materials
All chemicals were obtained from Sigma Chemical Co., St. Louis, Mo. 63178, except where noted. All reagents were prepared freshly for each assay and kept on ice during the assay. This ensured the stability of the reagent mix over the assay period. DTNB: Dissolve 16.0 mg of DTNB and 480.0 mg of tris(hydroxymehyl)methylamine ("Trizma") in 100.0 ml of distilled water. Adjust the pH to 7.5 (at 24 #{176}C) with concentrated HC1 and dilute to 20.0 ml with distilled water. The final concentration is thus 0. 3 .0 ml of S-acetyl coenzyme A solution and 12.0 ml of distilled water, to give a total volume of 30.0 ml. Fi-nally add 30 Ml of the enzyme suspension (about 105 U/ml) to 14 ml of the mix. This amount of mix is sufficient to measure test, reagent, and water blanks on 30 specimens (see Procedure for details). If two or three runs (60 or 90 specimens) are to be assayed, use 40 and 60 ml of the mix and add appropriate amount of enzyme suspension to 20 and 30 ml, respectively (e.g., 60 Ml to 30 ml). The final concentrations of the individual components of the mix in the cuvette (with sampleto-mix ratio of 1/10, e.g., 25 itl/250 Ml), are: CoA, 0.55 iimol; DTNB, 55 iimol; and enzyme (when added), about 0.3 U.
Apparatus
Membrane filter cones (CF5OA), centrifuge tubes and conical supports (CST1) were from Amicon Corp., Lexington, Mass. 02173.
Spectrophotometer (SOP-800A), Unicam Instruments Ltd., Cambridge, England. Bichromatic analyzer (ABA-100), Abbott Laboratories, N. Chicago, Ill. 60064.
Refrigerated centrifuge.
Subjects and Sample Preparation
Forty-seven apparently healthy laboratory employees [27 women and 20 men, average age 30±7.5 (SD) yearsj volunteered to give blood after a minimum of 12 h overnight fast. Blood was collected into evacuated tubes, either plain or with heparin or oxalate fluoride present as anticoagulants.
Serum (after clotting) or plasma was separated and either analyzed immediately or stored frozen at -40 #{176}C for one to 30 weeks. We saw no significant differences in values obtained on serum and plasma or fresh and stored specimens.
Procedure
Deproteinization:
Centrifuge about 0.5 to 1 ml of serum in a membrane filter cone at 2000 rpm for 20 mm at 10#{176}C. Use only new cones. Use lOO-M'aliquots of the ultrafiltrate in the assay. Treat aqueous carnitine standards and aliquots of pooled serum (quality control) identically.
Automated assay: Fit the Abbott ABA-100 with a 415/550 nm filter, set incubator to 37 #{176}C, analysis time to 10 mm, reaction direction to "Down," and kinetics to "Endpoint." Switch the machine to "Test" mode and calibrate it to read four decimal places (.0000). Attach 1:11 syringe plate and flush manually several times with the reagent mix without enzyme. Put cups with 100 Ml of specimen (or standards and quality control) into the carousel, and follow each such specimen cup with a cup containing 100 Ml of distilled water (reagent blanks). Dispense specimens (and water blanks) in the first cycle and the reagent mix without the enzyme in the second cycle, no mix being added into cuvette no. 1. The change in absorbance, #{163}4, is read after 10 min (reagent blanks). Next, replace the reagent mix by the mix containing the enzyme. Flush the tubing and repeat the whole assay (the water cups now serve as "enzyme blanks"). 
Calculation
1. LA of the specimen in the run with the enzyme -#{163}4 of the blank in the run with the enzyme = X.
Results
It has been reported (12) that inconsistent results were obtained for carnitine determinations in whole serum, and deproteinization of the samples was recommended.
With the deproteinization procedure described above, the original protein content (75 ± 10 g/liter) of serum was decreased to 0.70 ± 0.10 g/litermore than 98% of the protein was removed. With this deproteinization procedure, 45-50% of the original volume was lost. The above values were obtained with new cones. When cones were washed and re-used as outlined by the manufacturer, the efficiency of protein removal was not altered but the volume recovered decreased to 20-25% of the original. We thus recommend that a new cone be used for the deproteinization of small samples.
The efficiency of the above deproteinization procedure was compared to the standard barium hydroxide and zinc sulfate method. The conditions for deproteinization by the latter method were tested, and the following procedure proved to be optimal: An 80 mmol/liter solution of zinc sulfate, 0.25 ml, was added to 0.5 ml of serum and mixed thoroughly. Subsequently, 0.25 ml of barium hydroxide (80 mmol/liter solution) was added and the resulting precipitate removed by centrifugation (4000 rpm, 15 mm). A 0.5-ml aliquot of the supernate was taken and the additions were both repeated. All of the above was done at 0-4 #{176}C. The average serum protein content decreased to about 27-33 g/liter after the first precipitation step and to about 1.5-2.5 g/liter after the second. Only the second supernate was satisfactory for the spectrophotometric assay of carnitine. The threefold dilution incurred by chemical deproteinization severely limited the sensitivity of the assay procedure at lower concentrations.
Another important consideration was the difference in analytical recovery of carnitine between the two deproteinization procedures.
In the case of the zinc sulfate/barium hydroxide precipitation, analytical recovery was virtually 100%. In contrast, recovery of ['4C]carnitine from sera by the cone procedure was 84.2 ± 1.9%; in similar experiments in which water standards were used, recovery of [14Cjcarnitine was 87.9 ± 1.2%. Thus binding of carnitine to the membrane cone is not related to the presence of protein. To compensate for carnitine loss on the membrane, we identically "deproteinized" all standards, quality controls, and serum samples before they were assayed.
Assay Conditions
The optimal concentrations of reagents were determined by assaying mmol/liter), and enzyme (10-240 U/ml) present. As did Marquis and Fritz (8) , we found the optimal concentrations to be 0.2 and 2.0 mmol/liter for DTNB and acetyl CoA, respectively.
The presence of increasing amounts of enzyme always resulted in an increase of nonspecific absorbance and necessitated the introduction of an "enzyme blank" (see Procedure).
The apparent Km of the enzyme for acetyl CoA is 4 X 10 mmol, and this justifies the use of the concentrations indicated above. Figure 1 shows the absorption spectrum for DTNB with (A) and without SH-group (mercaptoethanol) protection (B). Obviously, deterioration of the "reagent mix" leads to a change in #{163}4 415/550. Also, in both curves (A and B) the difference between absorbance at 412 (optimum absorbance) and 415 nm is negligible; hence use of the commercially available 4 15/550 filter does not decrease the sensitivity of the method. At the temperature we used (37 #{176}C), the reaction is complete in 10 mm.
Comparison with the Manual Method (8)
Parallel assays were run on sera with various carnitine concentrations, by both the automated and the manual methods. The results give a correlation coefficient of 0.989 for 11 pairs.
Normal Values
Normal values for carnitine in the serum of healthy adult volunteers as assayed by the automated method are summarized in Table 1 . The mean and the range agree well with data from other laboratories, also shown in Table 1 . The quality-control serum used in our assay was prepared by pooling sera from about 200 inpatients and its average carnitine concentration (51.1 Mmol/hter) is, as would be expected, very close to the mean for normal subjects.
Analytical Variables
Accuracy: Based on the degree of enzyme specificity, the use of aqueous L-carnitine standards, and the analytical recovery from serum-based standards, we are confident that the accuracy of this modification is at least as good as that of the original method (8). 
Discussion
Our automated determination of L-carnitine is a time-saving modification of a specific, precise, manual enzymatic method. After deproteinization, 80 samples can be assayed in one working day with the Abbott ABA-100. In contrast, in one working day with the zinc sulfate/barium hydroxide deproteinization and manual use of a spectrophotometer one can obtain about 20 results. Therefore our method is more suitable for mass-screening programs and utilizes equipment that is widely available in hospital laboratories. Advantages of this method over the manual technique include not only savings in time, but also in expensive reagents and sample aliquots (a quarter of the amounts used in a manual assay are used in the automated assay). In addition, automated pipetting and mixing improves the precision of the method. Possible clinical applications include the assessment of patients with muscle and metabolic disorders, a fruitful field currently being investigated.
